Regent Peak Wealth Advisors LLC Invests $125,000 in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Regent Peak Wealth Advisors LLC bought a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the fourth quarter, HoldingsChannel reports. The institutional investor bought 13,401 shares of the pharmacy operator’s stock, valued at approximately $125,000.

Other large investors also recently modified their holdings of the company. State Street Corp boosted its position in Walgreens Boots Alliance by 18.0% during the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after acquiring an additional 6,569,223 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in Walgreens Boots Alliance by 43.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after buying an additional 3,329,857 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Walgreens Boots Alliance by 12.1% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after purchasing an additional 817,762 shares in the last quarter. Thompson Siegel & Walmsley LLC raised its position in Walgreens Boots Alliance by 15.5% during the third quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock valued at $62,325,000 after buying an additional 934,754 shares during the period. Finally, FMR LLC boosted its stake in shares of Walgreens Boots Alliance by 2.5% during the 3rd quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator’s stock valued at $29,200,000 after buying an additional 80,525 shares during the period. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on WBA shares. Royal Bank of Canada upped their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. UBS Group upped their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Bank of America boosted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th. Jefferies Financial Group lowered their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Finally, Truist Financial upped their target price on shares of Walgreens Boots Alliance from $10.00 to $13.00 and gave the company a “hold” rating in a research report on Thursday, January 16th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus price target of $13.27.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $12.52 on Tuesday. The company’s fifty day moving average is $9.57 and its 200 day moving average is $9.83. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $23.76.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance’s revenue was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.66 EPS. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.59 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 7.99%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -9.77%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.